Sunday - December 22, 2024

Carboxamides as Ubiquitin-Specific Protease Inhibitors

2024-12-10

ALEXANDRIA, Virginia, Dec. 10 -- VALO HEALTH, INC., Boston, Massachusetts has been assigned a patent (No. US 12162888 B2, initially filed Aug. 8, 2019) developed by nine inventors David J. Guerin, Natick, Massachusetts; Pui Yee Ng, Lexington, Massachusetts; Zhongguo Wang, Lexington, Massachusetts; Tatiana Shelekhin, Ridgefield, Connecticut; Justin Caravella, Cambridge, Massachusetts; Mary-Margaret Zablocki, Revere, Massachusetts; Jennifer R. Downing, Clinton, Massachusetts; Hongbin Li, Madison, . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Carboxamides as Ubiquitin-Specific Protease Inhibitors

Information Request Form

Copyright Targeted News Service 2024